Epidemiologic and Clinical Characteristics of the 385 Hemophilic Patients Enrolled Onto the Study
| Characteristic . | No. . | % . |
|---|---|---|
| Sex | ||
| Male | 377 | 98 |
| Female | 8 | 2 |
| Age (yr)* | 31 (10-83) | |
| Type of hemophilia | ||
| A severe | 234 | 61 |
| A moderate/mild | 77 | 20 |
| B severe | 48 | 12 |
| B moderate/mild | 12 | 3 |
| von Willebrand disease | 14 | 4 |
| Duration of infection (mo)* | 240 (120-588) | |
| Cirrhosis | 40 | 10 |
| Anti-HCV alone | 355 | 92 |
| HBsAg + anti-HCV | 29 | 7.5 |
| HBsAg alone | 1 | 0.3 |
| Anti-HIV | 141 | 37 |
| Treated with interferon | 15 | 4 |
| Characteristic . | No. . | % . |
|---|---|---|
| Sex | ||
| Male | 377 | 98 |
| Female | 8 | 2 |
| Age (yr)* | 31 (10-83) | |
| Type of hemophilia | ||
| A severe | 234 | 61 |
| A moderate/mild | 77 | 20 |
| B severe | 48 | 12 |
| B moderate/mild | 12 | 3 |
| von Willebrand disease | 14 | 4 |
| Duration of infection (mo)* | 240 (120-588) | |
| Cirrhosis | 40 | 10 |
| Anti-HCV alone | 355 | 92 |
| HBsAg + anti-HCV | 29 | 7.5 |
| HBsAg alone | 1 | 0.3 |
| Anti-HIV | 141 | 37 |
| Treated with interferon | 15 | 4 |
*Median (range).